N/A
N=50
Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI
Peripheral Artery Disease
Bottom Line
View on ClinicalTrials.gov: NCT03943160 ↗Enrolled (actual)
50
Serious AEs
4.0%
Results posted
Mar 2021
Primary outcome: Primary: Procedural Success: — 49 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Diamondback 360 Extended Length Orbital Atherectomy System (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Abbott Medical Devices
- Primary completion
- Dec 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Procedural Success: |
49 | — |
| SECONDARY Treatment Success: |
49 | — |
Summary
The objective of this study is to evaluate acute clinical results of orbital atherectomy (OA) via radial artery access, including complication rates and cost effectiveness.
Eligibility Criteria
Inclusion Criteria
- Subject is ≥ 18 years
- Subject is willing and able to sign the IRB-approved informed consent form (ICF)
- Subject presents with a Rutherford Classification of 2 to 5
- Subject has a positive Allen's Test
- Subject to undergo peripheral angiography and/or PVI via TRA approach per physician discretion
Index Procedure Inclusion Criteria:
- Physician obtains successful radial artery access (Note: snuffbox access is allowed)
- Target lesion appropriate (i.e. location/morphology) for OA treatment via TRA within target area
- OAS use attempted (defined as ViperWire introduced into the body)
Exclusion Criteria
- Subject has no palpable radial artery on the planned access arm
- Subject has a previous failed radial access attempt on planned access arm
- Subject has a dialysis fistula on planned access arm
- Subject has a known subclavian stenosis or occlusion
- Subject has a previous subclavian stent or previous subclavian intervention
- Subject has a shunt in the radial artery on the planned access arm
- Subject has evidence of osteomyelitis
- Subject is currently participating in an investigational drug or device study
- Subject is pregnant within the study period
Index Procedure Exclusion Criteria
- Physician unable to obtain radial artery access
- Physician determines TRA is not acceptable due to patient anatomy, lesion characteristics, and/or disease severity
- OAS use not attempted (defined as ViperWire introduced into the body)
Prior to insertion of ViperWire:
- Femoral access is obtained
- Unsuccessful peripheral intervention
- A reportable adverse event has occurred
Data sourced from ClinicalTrials.gov (NCT03943160). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.